Daclatasvir Tablets 60 mg

Description

Indications:

• Chronic Hepatitis C Virus (HCV) infection
• Used in combination therapy with other antiviral agents

Key Features:

• Potent and selective NS5A inhibitor
• Once-daily oral tablet
• High efficacy across HCV genotypes 1, 3, and others
• Enhances Sustained Virologic Response (SVR) when used in combination

Global Manufacturing & Export:

This product is manufactured in WHO-GMP accredited facilities designed per EU-GMP standards. Aetos Life Care exports Daclatasvir Tablets 60 mg to regulated and semi-regulated markets across Latin America, Africa, Asia, CIS, and the Middle East. The product complies with international quality, safety, and documentation requirements.

Third-Party Contract Manufacturing:

We offer third-party contract manufacturing for Daclatasvir Tablets 60 mg with customized branding, packaging, and regulatory support. Our flexible and scalable production capabilities make us a reliable partner for international pharmaceutical companies seeking high-quality, compliant antiviral products.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.